BML Investment Partners, L.P. - 04 Dec 2025 SCHEDULE 13D/A Report for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: Leonard Braden Michael
Security: Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share
Symbol: ADVM
Shares outstanding: 22,163,711 shares
Disclosed Ownership: 2,149,880 shares
Ownership: 9.7%
Form type: SCHEDULE 13D/A
Filing time: 05 Dec 2025, 18:18:04 UTC
Date of event: 04 Dec 2025
Previous filing: 10 Nov 2025
Next filing: 09 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	8.9%	1,958,080	0	1,958,080	Braden M Leonard	Braden M Leonard - Managing Member of BML Capital Management, LLC	0001373604
Leonard Braden Michael	9.7%	2,149,880	191,800	1,958,080	Braden M Leonard	Leonard Braden Michael	0001373603